Tissue engineering could become new coronary bypass

November 14, 2001

ANN ARBOR---A spongy plastic material impregnated with two kinds of growth factor has been shown to encourage the formation of healthy new blood vessels in living rats, according to a tissue engineering research team at the University of Michigan.

The ability to grow new blood vessels in a controlled fashion could lead to better treatments for coronary artery disease, to speed wound healing, or to help diabetic patients who are suffering from peripheral vascular disease.

"This new approach allows us to deliver a controlled dose of growth factors to a specific tissue," said David J. Mooney, a professor of biologic and materials science in U-M's College of Engineering and School of Dentistry. "To grow a replacement tissue cell by cell, you need a combination of growth factors delivered in the right sequence at the proper time and in the right place. Just injecting a large amount of it with a needle doesn't work."

Coronary artery disease occurs when blocked vessels fail to deliver enough blood and oxygen to the heart muscle itself. The coronary bypass operation, which is performed nearly 3 million times per year in the United States, involves removing an artery or vein from one part of the body and then stitching it onto the threatened area of the heart. The ribcage must be cut open, and the heart's beating is stopped during the procedure.

However, this polymer may be able to grow new vessels on site with much less invasive surgery.

Two naturally-occurring growth factor chemicals are key to the formation of proper blood vessels, VEGF, the Vascular Endothelial Growth Factor, and PDGF, the Platelet-Derived Growth Factor. But simply basting an area of tissue with both chemicals does not result in satisfactory angiogenesis, or vessel development. The vessels may form, but they end up falling apart because they are not constructed properly. And if VEGF levels fall too low, vessels are even subject to "pruning and remodeling," the researchers report.

The new polymer formulation combines proper doses of VEGF and PDGF in a way that encourages the proper structure of vessels and guides their growth for weeks. It was developed in Mooney's labs at the School of Dentistry and the College of Engineering with graduate students Thomas P. Richardson, Martin C. Peters and Alessandra B. Ennett, and was reported in the November 2001 edition of Nature Biotechnology.

In the polymer, VEGF starts the process of angiogenesis and recruits the endothelial cells which line blood vessels. PDGF then recruits smooth muscle cells to form the resilient outer layer of the artery or vein. Only with the two chemicals working together in appropriate doses do robust vessels develop. The U-M team hit on a way to release VEGF from the polymer immediately in the first few days after implantation, and then to slowly release measured doses of PDGF by using microcapsules that dissolve over time. The polymer itself will also melt away over time.

"The polymer might be used as a heart patch," Mooney said. "You'd lay a sheet of it on the muscle and it could encourage the formation of a lot of vessels through it and around it."

To test the polymer, the researchers implanted four different versions of the material under the skin on the backs of laboratory rats. One polymer held just VEGF, one just PDGF, one had both with the PDGF in time-release microcapsules, and one was just the semi-porous polymer without any added growth factors.

The VEGF by itself led to a dramatic increase in vessel formation, but the vessels were smaller than normal and were missing some of the cell types they needed to function well. PDGF by itself did not lead to any appreciable difference in the formation of blood vessels, though the existing vessels around the polymer did appear to grow larger in the presence of the growth factor.

Together, however, the growth factors created new blood vessels that were large and well-formed.

Though polymer "scaffolds" have been used in a variety of tissue engineering experiments, this is the first time multiple growth factors have been incorporated for release in a controlled-dose fashion. Mooney is confident his team will be able to impregnate a polymer with several growth factors and to release them in a timed fashion.

This new ability to deliver multiple growth factors in a controlled way has applications to many other kinds of tissue engineering beyond angiogenesis, Mooney said, since tissue formation probably rarely relies on just a single chemical signal.
On the Web:

David J. Mooney's Research, http://www.engin.umich.edu/dept/che/research/mooney/. Biomedical Engineering Department, http://www.bme.umich.edu/

Contact: Neal J. Lao, 734-647-7087 njlao@umich.edu or Colleen Newvine, 734-647-4411 cnewvine@umich.edu

University of Michigan

Related Blood Vessels Articles from Brightsurf:

Biofriendly protocells pump up blood vessels
In a new study published today in Nature Chemistry, Professor Stephen Mann and Dr Mei Li from Bristol's School of Chemistry, together with Associate Professor Jianbo Liu and colleagues at Hunan University and Central South University in China, prepared synthetic protocells coated in red blood cell fragments for use as nitric oxide generating bio-bots within blood vessels.

Specific and rapid expansion of blood vessels
Upon a heart infarct or stroke, rapid restoration of blood flow, and oxygen delivery to the hypo perfused regions is of eminent importance to prevent further damage to heart or brain.

Flexible and biodegradable electronic blood vessels
Researchers in China and Switzerland have developed electronic blood vessels that can be actively tuned to address subtle changes in the body after implantation.

Lumpy proteins stiffen blood vessels of the brain
Deposits of a protein called ''Medin'', which manifest in virtually all older adults, reduce the elasticity of blood vessels during aging and hence may be a risk factor for vascular dementia.

Cancer cells take over blood vessels to spread
In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

Novel function of platelets in tumor blood vessels found
Scientists at Uppsala University have discovered a hitherto unknown function of blood platelets in cancer.

Blood vessels can make you fat, and yet fit
IBS scientists have reported Angiopoietin-2 (Angpt2) as a key driver that inhibits the accumulation of potbellies by enabling the proper transport of fatty acid into general circulation in blood vessels, thus preventing insulin resistance.

Brothers in arms: The brain and its blood vessels
The brain and its surrounding blood vessels exist in a close relationship.

Feeling the pressure: How blood vessels sense their environment
Researchers from the University of Tsukuba discovered that Thbs1 is a key extracellular mediator of mechanotransduction upon mechanical stress.

Human textiles to repair blood vessels
As the leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates.

Read More: Blood Vessels News and Blood Vessels Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.